EDGAR Filing Documents for 9999999995-18-000654

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-18-000654

Accepted

2018-03-23 00:15:16

Documents

Effectiveness Date

2018-03-22

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	588
	Complete submission text file	9999999995-18-000654.txt		2007

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)